Oncimmune is a leading early cancer detection company. It has pioneered the development of autoantibody assay technologies that have the potential to allow cancer detection up to four years earlier than other methods and can be applied to a wide range of solid tumour types. Oncimmune Ltd is headquartered in Nottingham, UK and testing is conducted in our CLIA-approved laboratory, based in Kansas City, USA.
Company type
Dr Mike Fisher
Commercial Director 

One Nucleus

Meet One Nucleus at the UK Pavilion

Oxford Brain Diagnostics

Meet Oxford Brain Diagnostics at the UK Pavilion

Company type
Mr Terry Pollard
Chief Operating Officer 

OxStem Limited

Company type
Dr Carolyn Porter
Chief Business Officer 
Dr Stuart Collinson

Phion Therapeutics

Meet Phion Therapeutics at the UK Pavilion

PhoreMost Ltd

PhoreMost is a new-model drug discovery company based in Cambridge, UK: Using its core expertise to open up new ‘druggable’ target space and working with a global network of co-invested academic and industrial collaboration partners, we aim to bring a wide array of novel ‘targeted’ therapies more efficiently to market and pass these cost savings onto patients.

Company type
Dr Sam Barker
BD & Alliances 
Dr Neil Torbett

Random 42

Leave a messge for Random 42 at the UK Pavilion


Meet Randox at the UK Pavilion

Richmond Pharmacology

Meet Richmond Pharmacology on the UK Pavilion

Scottish Development Internationanl

Meet SDI at the Scotland stand